Correlation of Cough With Disease Activity and Treatment With Cyclophosphamide in Scleroderma Interstitial Lung Disease

Chest - United States
doi 10.1378/chest.11-0801
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Interstitial Lung Disease in Patients With Scleroderma: Treatment With Rituximab

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2011English

Cyclophosphamide Versus Placebo in Scleroderma Lung Disease

New England Journal of Medicine
Medicine
2006English

Treatment of Scleroderma-Interstitial Lung Disease With Cyclophosphamide Is Associated With Less Progressive Fibrosis on Serial Thoracic High-Resolution CT Scan Than Placebo

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2009English

Emphysematous Change With Scleroderma-Associated Interstitial Lung Disease: The Potential Contribution of Vasculopathy?

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2018English

Treatment of Interstitial Lung Disease Associated Cough: CHEST Guideline and Expert Panel Report

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2018English

Physical Activity in People With Asbestos Related Pleural Disease and Dust-Related Interstitial Lung Disease

Chronic Respiratory Disease
PulmonaryRespiratory Medicine
2015English

Respiratory Bronchiolitis With Interstitial Lung Disease

2010English

Extrinsic Interstitial Lung Disease Activity Markers

Pulmonologiya
PulmonaryRespiratory Medicine
2016English

Inhibition of Thrombin as a Novel Strategy in the Treatment of Scleroderma-Associated Interstitial Lung Disease

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy